- ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.
Stocks are lower Monday as Wall Street's attention shifts to the looming presidential debate from central bank policy.
The FDA approved Amgen's (AMGN) generic version of AbbVie's (ABBV) Humira drug.
UnitedHealth becomes the second major healthcare provider to scratch the insulin product from its 2017 medicines roster.